Heartflow Inc Revenue Growth Rates (HTFL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Heartflow Inc   (NASDAQ: HTFL)
 

HTFL's Revenue Growth by Quarter and Year

Heartflow Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/HTFL/growth
https://api.csimarket.com/api/v1/companies/HTFL/fundamentals
https://api.csimarket.com/api/v1/companies/HTFL/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
HTFL Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 72.86
2nd Quarter June 64.08
1st Quarter March 52.16
FY 189.10





HTFL Revenue third quarter 2026 Y/Y Growth Comment
Heartflow Inc achieved in the third quarter 2026, above Company average Revenue rise of 60.41% year on year, to $ 72.86 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 146 other companies have achieved higher Revenue growth. While Heartflow Inc ' s Revenue jump of 60.41% ranks overall at the positon no. 3024 in the third quarter 2026.


HTFL Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 60.41 %
2nd Quarter June 49.79 %
1st Quarter March 40.18 %
FY   -

Financial Statements
Heartflow Inc 's third quarter 2026 Revenue $ 72.86 millions HTFL's Income Statement
Heartflow Inc 's third quarter 2025 Revenue $ 45.42 millions Quarterly HTFL's Income Statement


HTFL Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 13.7 %
2nd Quarter June 22.85 %
1st Quarter March 6.17 %
FY (Year on Year)   -


Back to HTFL Growth rate Comparisons >> Back to HTFL Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #147
Healthcare Sector #414
Overall #3024

Revenue Y/Y Growth Statistics
High Average Low
20.63 % 18.44 % 16.24 %
(Jun 30 2026)   (Mar 31 2026)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #147
Healthcare Sector #414
Overall #3024
Revenue Y/Y Growth Statistics
High Average Low
20.63 % 18.44 % 16.24 %
(Jun 30 2026)   (Mar 31 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Heartflow Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
87.71 % 14.04 % -39.82 %
(Dec 31 2024)  


HTFL's III. Quarter Q/Q Revenue Comment
Heartflow Inc achieved in the III. Quarter 2026 below company average Revenue rise of 13.7% quarter on quarter, to $ 72.86 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 6.17% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Heartflow Inc 's Revenue growth quarter on quarter, overall rank is 455.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #96
Overall #455
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #96
Overall #455
Revenue Q/Q Growth Statistics
High Average Low
87.71 % 14.04 % -39.82 %
(Dec 31 2024)  


HTFL's III. Quarter Q/Q Revenue Comment
Heartflow Inc achieved in the III. Quarter 2026 below company average Revenue rise of 13.7% quarter on quarter, to $ 72.86 millions.

III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 6.17% in the III. Quarter a year ago.

Within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Heartflow Inc 's Revenue growth quarter on quarter, overall rank is 455.


Heartflow Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 238.23
Y / Y Revenue Growth (TTM) 27.25 %
Year on Year Revenue Growth Overall Ranking # 1031
Seqeuential Revenue Change (TTM) 13.02 %
Seq. Revenue Growth (TTM) Overall Ranking # 3089


Cumulative Revenue growth Comment
Heartflow Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 27.25% year on year, to $ 238 millions if the fiscal year would have ended in Sep 30 2026.
Heartflow Inc 's trailing twelve months Revenue growth was higher than company's average 18.44% and higher than 20.63% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 13.02 % from $210.79 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at18.44%.

In the Healthcare sector 200 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 380 to 1031.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 150
Healthcare Sector # 201
Overall # 1031

Revenue TTM Y/Y Growth Statistics
High Average Low
20.63 %
 18.44 %
16.24 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 150
Sector # 417
S&P 500 # 3089
Cumulative Revenue growth Comment
Heartflow Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 27.25% year on year, to $ 238 millions if the fiscal year would have ended in Sep 30 2026.
Heartflow Inc 's trailing twelve months Revenue growth was higher than company's average 18.44% and higher than 20.63% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 13.02 % from $210.79 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at18.44%.

In the Healthcare sector 200 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 380 to 1031.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 150
Healthcare Sector # 201
Overall # 1031

Revenue TTM Y/Y Growth Statistics
High Average Low
20.63 %
18.44 %
16.24 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 150
Sector # 417
S&P 500 # 3089




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
HTFL's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Co diagnostics Inc 94.58%$ 94.580 millions
Autolus Therapeutics Plc94.57%$ 94.574 millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________93.02%$ 93.022 millions
Keros Therapeutics Inc 88.77%$ 88.766 millions
Profound Medical Corp 85.86%$ 85.857 millions
Vivosim Labs Inc 82.14%$ 82.143 millions
Syndax Pharmaceuticals Inc 81.59%$ 81.592 millions
Nuo Therapeutics Inc 80.81%$ 80.809 millions
Iovance Biotherapeutics inc 80.07%$ 80.074 millions
Rhythm Pharmaceuticals Inc 79.59%$ 79.594 millions
Omniab Inc 78.34%$ 78.339 millions
Aclarion Inc 78.09%$ 78.086 millions
Personalis Inc 76.59%$ 76.585 millions
Delcath Systems Inc 76.05%$ 76.047 millions
Mobia Medical Inc 73.28%$ 73.280 millions
Wave Life Sciences Ltd 72.95%$ 72.950 millions
Igc Pharma Inc 71.73%$ 71.728 millions
Phathom Pharmaceuticals Inc 71.14%$ 71.142 millions
Ptc Therapeutics inc 69.57%$ 69.571 millions
Seres Therapeutics Inc 68.95%$ 68.946 millions
Alamar Biosciences Inc 68.46%$ 68.458 millions
Carlsmed Inc 66.74%$ 66.736 millions
Corcept Therapeutics Inc63.97%$ 63.974 millions
Tarsus Pharmaceuticals Inc 63.92%$ 63.921 millions
Tg Therapeutics Inc 60.74%$ 60.743 millions
Therapeuticsmd Inc 60.59%$ 60.587 millions
Heartflow Inc 60.42%$ 60.425 millions
Glaukos Corp59.02%$ 59.021 millions
X4 Pharmaceuticals Inc58.64%$ 58.640 millions
Kiniksa Pharmaceuticals International Plc58.12%$ 58.121 millions


About Heartflow Inc Revenue Growth Rates (HTFL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Heartflow Inc (CIK 1464521).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001464521-26-000173
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Heartflow Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.